Key result
Constitutive GSK-3β activation prevents age-related cardiac dysfunction and fibrosis by preserving Ulk1-dependent autophagy.
Why the study?
The role of GSK-3β and its Ser9 phosphorylation in mediating cardiac aging and the underlying mechanism remained poorly understood.
Does preventing age-dependent Ser9 phosphorylation of GSK-3β preserve cardiac autophagy via Ulk1 Ser913 phosphorylation and attenuate cardiac aging and dysfunction in mice?
Does preventing age-dependent Ser9 phosphorylation of GSK-3β preserve cardiac autophagy via Ulk1 Ser913 phosphorylation and attenuate cardiac aging and dysfunction in mice?
This preclinical study identifies age-related Ser9 phosphorylation (inactivation) of GSK-3β as a driver of cardiac aging and demonstrates that active GSK-3β directly phosphorylates Ulk1 at Ser913 to maintain myocardial autophagy and prevent age-related systolic and diastolic dysfunction.
Answers are grounded in this paper and cite their sources.
GSK-3β activation attenuates murine cardiac aging via Ulk1; leaves open whether this axis offers therapeutic targets in humans.
INTRODUCTION: Glycogen synthase kinase-3β (GSK-3β) is a serine/threonine kinase and a negative regulator of cardiac hypertrophy. Phosphorylation of GSK-3β at Ser9 negatively regulates its kinase activity. The role of GSK-3β in cardiac aging remains poorly understood. AIM: The study aimed to elucidate the role of GSK-3β Ser9 phosphorylation in mediating cardiac aging and the underlying mechanism. METHODS AND RESULTS: reversed the age-associated decline in autophagy in the mouse heart. GSK-3β directly phosphorylates Ulk1, a regulator of autophagy, at Ser913, thereby stimulating autophagy in cardiomyocytes. Ulk1Ser913A KI mice exhibited decreased autophagic flux and increased senescence in cardiomyocytes. CONCLUSION: Our results suggest that GSK-3β is inactivated during aging through Ser9 phosphorylation, which in turn plays an important role in mediating cardiac aging. GSK-3β promotes autophagy through phosphorylation of Ulk1 at Ser913, which in turn prevents aging in the heart.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2021) studied Cardiac aging. Constitutively active GSK-3β (GSK-3β S9A knock-in [βKI]) and Ulk1S913A knock-in genetic modification vs. Wild-type (WT) control mice and LacZ-expressing control cardiomyocytes was evaluated on Age-associated decline in cardiac autophagy, cardiac function (LVEF, end-systolic elastance, chamber stiffness), cardiac remodeling (hypertrophy, fibrosis, apoptosis, senescence), and survival (p=<0.05). Constitutive activation of GSK-3β in S9A knock-in mice prevented age-related cardiac dysfunction, hypertrophy, fibrosis, and senescence at 24 months by phosphorylating Ulk1 at Ser913 to preserve autophagy.
Synapse has enriched 10 related papers. Consider them for comparative context: